Judge Sides with Defendant McNeil Holding It is a Citizen of New Jersey, Not Pennsylvania
U.S. District Judge Mary A. McLaughlin of the Eastern District of Pennsylvania rules that McNeil Pharmaceuticals is a corporate citizen of New Jersey, not Pennsylvania.
McNeil, a wholly owned subsidiary of Johnson […]
Another Medical School Likely to Ban Speaking Fees
The Oregon Health & Science University School of Medicine plans to recommend that researchers should no longer accept paid speaking fees from drug companies. The proposal is expected to be approved in about two months. Some staff members who received lucrative compensation from drugmakers have voiced criticism.
The proposal comes a […]
AstraZeneca to Cut 1600 Jobs
On March 18, 2013, AstraZeneca (AZ) announced that it will consolidate its Research & Development operations and as a result, 1600 jobs will be lost globally by 2016, with a majority in the U.S. and UK. AZ plans to invest in research centers in the UK, U.S. and Sweden “to improve pipeline productivity and to establish the company as a global leader in biopharmaceutical […]
ProPublica Adds Searchable Physician Medicare Part D Prescribing Database
ProPublica has added yet another valuable tool, this one to researching drug prescribing patterns and individual physician scrip data. See one of the articles in their investigative series below.
Find the searchable database […]
Docs and Pharma Payments: Sunshine Act Now In Force
August 1 marked the first day the new Physician Payments Sunshine Act (PPSA), requiring pharmaceutical companies record all payments to physicians in preparation for submission to the Center for Medicare and Medicaid Services in May, 2014. CMS will then assemble a database to be released online September of 2014 […]